CPT code 64611 represents bilateral chemical denervation of the parotid and submandibular salivary glands. The procedure is used to reduce saliva production and lower aspiration risk in patients with disorders that cause excessive drooling or sialorrhea. Nationally, this code is relevant to otolaryngology, neurology, rehabilitation medicine, and interventional pain practices because it covers a targeted, minimally invasive intervention with implications for airway safety, oral hygiene, and quality of life.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides an overview of coding context and expected sites of service, and summarizes common modifiers and administrative considerations where available. Readers will find clinical context describing the intent and typical delivery of the service, billing and documentation touchpoints, and a summary of payer coverage patterns and benchmark considerations. The content is designed to inform billers, coding specialists, clinicians, and policy analysts about how CPT code 64611 is used, where it is typically performed, and what administrative elements commonly accompany claims. Data not available in the input is acknowledged where applicable.